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1144Objective: Thoracic empyema in cirrhotic patients is a challenging situation, and the clinical characteristics are
rarely reported. The objective of this study was to report the clinical characteristics among this group and to
evaluate whether thoracoscopic intervention would affect clinical outcomes.
Methods: Between 2001 and 2010, we retrospectively reviewed the clinical characteristics, bacteriologic stud-
ies, and treatment outcomes of 63 cirrhotic patients with thoracic empyema. A propensity-score based process,
matched on age, sex, diabetes mellitus, malignancy, cause, and Child-Pugh classification (A, B, or C), was per-
formed to equalize potential prognostic factors in thoracoscopy and nonthoracoscopy groups. The Kaplan–
Meier curve and log-rank test were applied to compare the survival to discharge between the 2 matched groups.
Results: The median patient age was 61 years. Thirty-two patients (51%) underwent thoracoscopic manage-
ment, and the remaining patients underwent thoracocentesis or tube thoracostomy. The median hospital stay
was 28 days, and 19 patients (30%) had in-hospital mortality. Multivariate analysis showed that Child-Pugh
C disease and positive blood cultures were risk factors for in-hospital mortality (P ¼ .016 and .027, respec-
tively), whereas thoracoscopic management may be favorable for survival (P ¼ .041). The propensity score–
matched analysis showed a significant reduction in intensive care unit stay (P¼ .044) in the thoracoscopy group.
Kaplan–Meier survival analysis revealed a higher survival to discharge, favoring thoracoscopy over non-
thoracoscopy treatment (P ¼ .035).
Conclusions:Management of thoracic empyema in cirrhotic patients is complicated and associated with a high
mortality. With proper patient selection, thoracoscopic management is feasible and may provide a better chance
of survival. (J Thorac Cardiovasc Surg 2012;143:1144-51)Thoracic empyema in patients with liver cirrhosis poses
a significant challenge to the clinician. In addition to
a higher risk of hepatic failure, the pleural infection makes
cirrhotic patients more susceptible to critical condition and
mortality. Cirrhosis is also regarded as a contraindication to
major surgery because of frequent hemostatic abnormalities
and malnutrition, which lead to increasing postoperative
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The Journal of Thoracic and Cardiovascular Surto die because of postoperative complications from hepatic
failure with intractable ascites.1 Moreover, surgical proce-
dures have a high risk of hemorrhage, infection, and meta-
bolic imbalance, and are sometimes withheld from cirrhotic
patients for fear of complications.
Since its introduction, video-assisted thoracoscopic sur-
gery (VATS) has become an attractive modality for treating
complicated empyema because of its minimal invasiveness
and satisfactory efficacy.2-7 Although clinical evidence
showing VATS is beneficial in the thoracic empyema, the
clinical characteristics and the role of VATS in managing
patients with empyema with liver cirrhosis are unknown.
We report our 10-year experience in managing cirrhotic pa-
tients with empyema, especially focusing on analysis of the
risk factors. We also examine the therapeutic effect of thor-
acoscopy in this specific group of patients, compared with
nonthoracoscopic treatment, on survival to discharge.MATERIALS AND METHODS
Patients
The medical records of all patients with thoracic empyema who were
discharged with a diagnosis of liver cirrhosis at the National Taiwan Uni-
versity Hospital and National Taiwan University Hospital Yun-Lin Branch,
a 3200-bed tertiary medical center, from January 2001 to June 2010 were
reviewed retrospectively. Exclusion criteria included empyema caused bygery c May 2012
Abbreviations and Acronyms
CI ¼ confidence interval
HBV ¼ hepatitis B virus
HCV ¼ hepatitis C virus
ICU ¼ intensive care unit
MRSA ¼ methicillin-resistant Staphylococcus
aureus
OR ¼ odds ratio
VATS ¼ video-assisted thoracoscopic surgery
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Sesophageal rupture, mediastinitis, tuberculosis, fungal infection, and post-
operative empyema. Information collected included demographic features,
clinical characteristics, microbiologic and laboratory data, radiographic
studies, hospital course, intervention modality, and treatment outcome.
The diagnosis of thoracic empyema was made if a patient had at least 1
of the following conditions: the presence of purulent material in the pleural
space, positive result for loculated pleural fluid culture or Gram stain for
microorganisms, and biochemical evidence suggestive of empyema.8 A di-
agnosis of liver cirrhosis was based on the patients’ clinical histories and
findings of typical morphologic change of the liver and spleen. The severity
of liver cirrhosis was graded according to the Child-Pugh classification,
which is based on the following 5 factors graded from 1 to 3: degree of en-
cephalopathy, ascites, prothrombin time, level of albumin, and total biliru-
bin.9 The cause of liver cirrhosis was established according to standard
criteria for infection with hepatitis B virus (HBV) (positive serum test
for hepatitis B surface antigen), hepatitis C virus (HCV) (seropositivity
for HCV antibody), coinfection HBV and HCV, or alcoholism related.
Other causes included autoimmune disease and cardiac liver cirrhosis.
When no cause was identified, liver cirrhosis was classified as cryptogenic.
The Research Ethics Committee of National Taiwan University Hospi-
tal approved this study and waived the requirement for informed consent
because of its retrospective nature (approval number: 201102015RC).
Demographic and Clinical Features
The algorithm for patient selection is shown in Figure 1. Sixty-three of
888 patients had liver cirrhosis (7.1%). The characteristics and demo-
graphics of the cirrhotic patients with thoracic empyema are listed in
Table 1. The median age was 61 years, and 39 patients were male. Most pa-
tients (87.3%) had chronic underlying diseases or associated medical con-
ditions, including malignancy (33.3%), diabetes mellitus (31.7%), hepatic
hydrothorax (30.2%), chronic renal insufficiency (22.2%), and congestive
heart failure (11.1%). Among those with malignancy, 18 patients (85.7%)
had hepatocellular carcinoma, 2 patients had buccal cancer, and 1 patient
had nasopharyngeal cancer. The causes of cirrhosis, the number of
Child-Pugh A, B, and C cases, and the inciting infections of thoracic em-
pyema are listed in Table 1.
Management
All patients received empiric broad-spectrum intravenous antibiotics as
soon as the diagnosis of thoracic empyema was suspected. Once the caus-
ative pathogenwas cultured, the antibiotics were adjusted according to sen-
sitivity testing results. Sonography-guided thoracocentesis was performed
on all patients, and the aspirates were sent for laboratory examination.
Chest computed tomography was performed to evaluate the extent of the
empyema and the severity of pulmonary parenchymal lesions, and all pa-
tients were noted with fibropurulent stage in this study. The primary phy-
sician selected repeated thoracocentesis, pigtail insertion, or tube
thoracostomy as the method of drainage. If drainage was not effective,The Journal of Thoracic and Carchest surgeons were consulted to evaluate the feasibility of thoracoscopic
management. Before diagnosis, thoracocentesis, and drainage of the empy-
ema, patients may have required albumin and blood component infusions
to improve hypoalbuminemia, anemia, thrombocytopenia, or prolonged
bleeding time or coagulation time. Patients were admitted to the intensive
care unit (ICU) for respiratory distress, organ failure, or unstable vital signs
requiring the use of inotropic agents, whether with or without surgical
intervention.
Thoracoscopic Procedures
The patients whowere treated with thoracoscopy underwent general an-
esthesia using double-lumen endotracheal tubes for selective 1-lung venti-
lation. The procedure was performed by means of a 3-port access. On the
basis of preoperative sonography and computed tomography, suitable inter-
costal sites were selected for port placement. Fluid, loculations, and septa
were removed under endoscopic vision. Adherent peel was carefully re-
moved from visceral pleural surface, and the lung was freed circumferen-
tially from the apex to the diaphragm. Complete decortication of the
visceral pleura and the fissures was performed by use of an endoscopic dis-
sector device and a peanut dissector as in open decortication. At the end of
the procedure, 2 chest tubes were placed. The abscess and necrotic tissue
from the empyema collection were sent for bacterial cultures and patho-
logic examination. The postoperative duration of drainage depended on
the patient’s clinical progress and results of the cultures of fluids aspirated
from the drainage tubes.
Statistical Analyses
The primary outcome variable assessed in this study was in-hospital
mortality. Categoric variables were compared using chi-square and Fisher
exact tests, and continuous variables were compare with the Student t test.
The median of hospital stays was compared byMann–WhitneyU test. Uni-
variate analyses were performed to assess the association between each risk
factor and in-hospital mortality. Variables that had a P value less than .1 in
the univariate analyses were subjected to multivariate analysis using a step-
wise binary logistic regression model. Odds ratios (ORs) and 95% confi-
dence intervals (CIs) were calculated to determine significance by
multivariate analysis. P values of less than .05 were regarded as significant.
Statistical analyses were performed using SPSS release 18 (SPSS Inc, Chi-
cago, Ill), and all statistical tests were 2-sided.
Propensity Score–Matching Methods
Propensity score matching is a method used to balance observed cova-
riates in the 2 treatment groups. In this study, the propensity score was the
conditional probability for receiving thoracoscopy, as a binary dependent
variable, under a set of measurements. Age, sex, diabetes mellitus, malig-
nancy, cause of empyema, and Child-Pugh class of liver cirrhosis were
added into a nonparsimonious multivariable logistic regression model to
predict the effect of thoracoscopy. The predicted probability derived
from the logistic equation was used as the propensity score for each indi-
vidual. Sixty-three patients were pooled and sorted according to their pro-
pensity score in ascending order. The selection process began from the first
2 cases with the lowest propensity score. If 1 case underwent thoracoscopy
and the other case underwent nonthoracoscopy management, both were se-
lected as a matched pair. If this was not the case, then 4 cases were in-
cluded. In the same way, thoracoscopy and nonthoracoscopy cases were
matched by their propensity score in 1:1, 2:2, 3:3, or 4:4 blocks. A patient
who did not have a suitable match within the acceptable rank rangewas ex-
cluded from further analysis, and the matching process moved down the
sort list until all possible matched pairs were included.10 The selected pa-
tients formed well-matched 1:1 pairs in both groups (thoracoscopy and
nonthoracoscopy). Kaplan–Meier curves, with follow-up until hospital
discharge, were plotted to show survival trend. Log-rank test was used to
compare the difference between the 2 matched groups. The survival timediovascular Surgery c Volume 143, Number 5 1145
FIGURE 1. Algorithm for patient selection.
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and as the duration from admission to discharge in the survivors. A logistic
regression model was used for the propensity score calculation using SPSS
release 18 (SPSS Inc). Propensity scores in both the thoracoscopy and non-
thoracoscopy groups were used to draw box-plots.
RESULTS
Bacteriology
Bacteriologic results from samples obtained from the
empyema specimens or blood showed 41 patients (65%)
with positive culture results, including positive empyema
cultures in 38 patients and positive blood cultures in 12 pa-
tients (Table 1). A total of 48 microorganisms were identi-
fied, including polymicrobial infections in 4 patients
(9.8%) and monopathogens in 37 patients (90.2%). The
most common pathogen was Klebsiella pneumonia, found
in 11 patients, which was followed by methicillin-
resistant Staphylococcus aureus (MRSA) in 7 patients
(Table 2). When the cause of empyema was stratified by
the pathogen isolated, we found K pneumoniae was the
most common pathogen in patients with parapneumonic1146 The Journal of Thoracic and Cardiovascular Surempyema, and Escherichia coli andMRSAwere more com-
mon in empyema due to hepatic hydrothorax (Table 2).Treatment and Outcome
Of the 63 patients, 32 finally underwent thoracoscopic
debridement and drainage of the empyema. The median du-
ration from admission to thoracoscopy was 3 days (range,
1–10 days). The median operation time was 113 minutes
(range, 48–172 minutes), and the median intraoperative
blood loss was 325 mL (range, 30–580 mL). After the oper-
ation, 4 patients (12.5%) required additional procedures for
complications, including 1 patient who required repeated
thoracoscopy for hemothorax and 3 patients who required
open drainage for residual empyema. The remaining 31 pa-
tients underwent thoracentesis or tube thoracostomy. The
median hospital stay was 28 days. Forty-eight patients
(76.2%) were admitted to the ICU for critical conditions,
with a ICU stay of 10 days. After treatment, 44 patients sur-
vived to discharge, whereas the remaining 19 patients
(30.2%) died in the hospital (Table 1). The mortality ratesgery c May 2012
TABLE 1. Clinical characteristics and treatment outcome of 63
cirrhotic patients with empyema
Variables
Result
No. (%), or median (range)
Age, y 61 (3880)
Male 39 (61.9%)
Ever smoker 33 (52.4%)
Right sided 43 (68.3%)
Comorbidity 55 (87.3%)
Malignancy 21 (33.3%)
Diabetes mellitus 20 (31.7%)
Hepatic hydrothorax 19 (30.2%)
Chronic renal insufficiency 16 (25.4%)
Congestive heart failure 7 (11.1%)
Cause of liver cirrhosis
HBV 28 (44.4%)
HCV 14 (22.2%)
HBV and HCV 5 (7.9%)
Alcoholism 7 (11.1%)
Autoimmune diseases 5 (7.9%)
Others 4 (6.3%)
Child-Pugh class
A 21 (33.3%)
B 17 (27.0%)
C 25 (39.7%)
Cause of empyema
Pneumonia 37 (58.7%)
Hepatic hydrothorax 19 (30.2%)
Others 7 (11.1%)
Positive bacterial culture 41 (65.1%)
Empyema 38 (60.3%)
Blood 12 (19.0%)
Thoracoscopic management 32 (50.8%)
Total hospital stay, d 28 (5150)
ICU stay, d 10 (089)
Mortality 19 (30.2%)
HBV, Hepatitis B virus; HCV, hepatitis C virus; ICU, intensive care unit.
TABLE 2. Microorganisms (n ¼ 48) isolated from 41 patients
Isolates
All
isolates
n ¼ 48
Cause of empyema
Pneumonia
n ¼ 27
Hepatic
hydrothorax
n ¼ 13
Others
n ¼ 8
Klebsiella
pneumoniae
11 (22.9%) 8 (29.6%) 1 (7.7%) 2 (25.0%)
MRSA 7 (14.6%) 3 (11.1%) 2 (15.4%) 2 (25.0%)
Escherichia coli 5 (10.4%) 2 (7.4%) 2 (15.4%) 1 (12.5%)
Streptococcus
constellatus
3 (6.3%) 2 (7.4%) 1 (7.7%) 0
Enterobacter
cloacae
3 (6.3%) 0 1 (7.7%) 2 (25.0%)
MSSA 2 (4.2%) 1 (3.7%) 1 (7.7%) 0
Enterococcus 2 (4.2%) 1 (3.7%) 0 1 (12.5%)
Pseudomonas
aeruginosa
2 (4.2%) 2 (7.4%) 0 0
Aeromonas
hydrophila
2 (4.2%) 1 (3.7%) 1 (7.7%) 0
A sobria 2 (4.2%) 1 (3.7%) 1 (7.7%) 0
S intermedius 2 (4.2%) 1 (3.7%) 1 (7.7%) 0
S anginosus 2 (4.2%) 2 (7.4%) 0 0
MRCNS 2 (4.2%) 1 (3.7%) 1 (7.7%) 0
PDRAB 2 (4.2%) 1 (3.7%) 1 (7.7%) 0
Salmonella 1 (2.1%) 1 (3.7%) 0 0
MRSA, Methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive
Staphylococcus aureus; MRCNS, methicillin-resistant coagulase-negative staphylo-
cocci; PDRAB, pan-resistant Acinetobacter baumaanii.
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in class A, 5.9% (1/17) in class B, and 60% (15/25) in class
C. The causes of mortality included sepsis in 9 patients,
multiple organ failure in 5 patients, hepatic failure in 4
patients, and intractable gastrointestinal bleeding in 1
patient.
To identify the factors associated with in-hospital mortal-
ity, the clinical characteristics, bacteriology, and manage-
ment between survivors and nonsurvivors are summarized
and compared in Table 3 by univariate analysis. We found
that patients with Child-Pugh class C and positive blood
cultures were associated with a higher rate of in-hospital
mortality. On the other hand, patients with male gender,
with Child-Pugh class B, and undergoing thoracoscopic
management were associated with a lower rate of in-
hospital mortality. Multivariate logistic regression analysis
showed that Child-Pugh class C (OR, 6.89; 95% CI, 1.43–
33.18) and positive blood cultures (OR, 13.97; 95% CI,The Journal of Thoracic and Car1.36–143.57) were risk factors for in-hospital mortality,
whereas thoracoscopic management may be favorable to
survival (OR, 0.16; 95% CI, 0.03–0.93) (Table 4).
Thoracoscopic Versus Nonthoracoscopic
Management
To analyze the role of thoracoscopic management in cir-
rhotic patients with empyema, patients were grouped ac-
cording to receiving or not receiving thoracoscopic
management. There were 32 patients in the thoracoscopy
group and 31 patients in the nonthoracoscopy group. Pa-
tients in the thoracoscopy group were associated with
a lower rate of Child-Pugh class C (21.9% vs 58.1%,
P ¼ .005), a shorter duration of ICU stay (median, 6 vs
15.0 days; P<.001), and a lower rate of in-hospital mortal-
ity (12.5% vs 48.4%, P¼ .003). The total hospital stay be-
tween the 2 groups was comparable (Table 5). The
propensity score-matching method selected 19 patients
from the thoracoscopy group and 19 patients from the
nonthoracoscopy group for further analysis (Figure 2, A
and B). Baseline characteristics, including age, gender, co-
morbidity, and Child-Pugh class, were all comparable in the
2 groups. The results showed that only ICU stay was longer
in the nonthoracoscopy group (median, 13 days) than in the
thoracoscopy group (6 days, P ¼ .044). The difference of
in-hospital mortality was nonsignificant (P ¼ .714, Table
6). Kaplan–Meier survival analysis revealed a higherdiovascular Surgery c Volume 143, Number 5 1147
TABLE 3. Clinical characteristics, bacteriology, and management
between survivors and nonsurvivors
Survivors
(N ¼ 44)
Nonsurvivors
(N ¼ 19)
Variables
No. (%), or
median (range)
No. (%), or
median (range)
P
value
Age, y 61 (3880) 63 (4977) .250
Male 31 (70.5%) 8 (42.1%) .048
Ever smoker 25 (56.8%) 8 (42.1%) .410
Right sided 29 (65.9%) 14 (73.7%) .769
Comorbidity
Malignancy 13 (29.5%) 8 (42.1%) .381
Diabetes mellitus 15 (34.1%) 5 (26.3%) .770
Hepatic hydrothorax 12 (27.3%) 7 (36.8%) .552
Chronic renal insufficiency 8 (18.2%) 8 (42.1%) .061
Congestive heart failure 5 (11.4%) 2 (10.5%) 1.000
Child-Pugh class <.001
A 18 (40.9%) 3 (15.8%) .080
B 16 (36.4%) 1 (5.3%) .013
C 10 (22.7%) 15 (78.9%) <.001
Cause of empyema
Pneumonia 26 (59.1%) 11 (57.9%) 1.000
Hepatic hydrothorax 12 (27.3%) 7 (36.8%) .552
Others 6 (13.6%) 1 (5.3%) .664
Positive culture
Empyema 26 (59.1%) 12 (63.2%) 1.000
Blood 3 (6.8%) 9 (47.4%) <.001
Causing pathogen
Klebsiella pneumoniae 7 (15.9%) 4 (21.1%) 1.000
MRSA 4 (9.1%) 3 (15.8%) .160
Escherichia coli 2 (4.5%) 3 (15.8%) .160
Others 18 (40.9%) 7 (36.8%) 1.000
Thoracoscopic management 28 (63.6%) 4 (21.1%) .003
MRSA, Methicillin-resistant Staphylococcus aureus.
TABLE 5. Clinical characteristics, bacteriology, and treatment
outcome between patients undergoing thoracoscopic and non-
thoracoscopic management
Thoracoscopy
(N ¼ 32)
Nonthoracoscopy
(N ¼ 31)
Variables
No. (%), or
median (range)
No. (%), or
median (range)
P
value
Age, y 59 (38–80) 62 (38–77) .390
Male 22 (68.8%) 17 (54.8%) .310
Ever smoker 18 (56.3%) 15 (48.4%) .617
Right sided 20 (62.5%) 23 (74.2%) .419
Comorbidity
Malignancy 11 (34.4%) 10 (32.3%) 1.000
Diabetes mellitus 14 (43.8%) 6 (19.4%) .060
Hepatic hydrothorax 6 (18.8%) 13 (41.9%) .060
Chronic renal
insufficiency
8 (25.0%) 8 (25.8%) 1.000
Congestive heart failure 5 (15.6%) 2 (6.5%) .430
Child-Pugh class .010
A 13 (40.6%) 8 (25.8%) .290
B 12 (37.5%) 5 (16.1%) .090
C 7 (21.9%) 18 (58.1%) .005
Cause of empyema
Pneumonia 21 (65.6%) 16 (51.6%) .311
Hepatic hydrothorax 6 (18.8%) 13 (41.9%) .058
Others 5 (15.6%) 2 (6.45%) .426
Positive culture
Empyema 21 (65.6%) 17 (54.8%) .446
Blood 5 (15.6%) 7 (22.6%) .536
Causing pathogen
Klebsiella pneumoniae 6 (18.8%) 5 (16.1%) 1.000
MRSA 5 (15.6%) 2 (6.5%) .430
Escherichia coli 1 (3.1%) 4 (12.9%) .196
Others 12 (37.5%) 13 (41.9%) .799
Total hospital stay, d 29 (9–150) 28 (5–56) .140
ICU stay, d 6 (0–70) 15 (0–89) <.001
Mortality 4 (12.5%) 15 (48.4%) .003
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thoracoscopy treatment (log-rank P ¼ .035, Figure 3).MRSA, Methicillin-resistant Staphylococcus aureus; ICU, intensive care unit.DISCUSSION
Our study aimed to identify the clinical characteristics
and prognostic factors affecting in-hospital mortality and
to analyze the role of thoracoscopic management in cir-
rhotic patients with thoracic empyema. The study showed
that management of thoracic empyema in cirrhotic patients
was challenging and associated with a high mortality rate,
especially when patients had Child-Pugh C disease andTABLE 4. Multivariant logistic regression analysis of risk factors
affecting mortality
Associated variables OR 95% CI P value
Male 0.51 0.102.59 .419
Chronic renal insufficiency 1.21 0.178.50 .848
Child-Pugh C* 6.89 1.4333.18 .016
Positive blood culture 13.97 1.36143.57 .027
Thoracoscopic management 0.16 0.030.93 .041
*Child–Pugh C vs Child–Pugh A and B.
1148 The Journal of Thoracic and Cardiovascular Surpositive blood cultures. Nonetheless, with comparable
baseline patient characteristics, thoracoscopic management
is feasible and may provide a better chance of survival than
nonthoracoscopic management.
Taiwan is an HBVand HCVendemic area11; therefore, it
was not surprising that the most common cause of liver cir-
rhosis was HBV infection, followed by HCV infection.12-14
In addition to liver cirrhosis, we also noticed that 87.3% of
our patients with empyema had additional chronic
underlying diseases or associated medical conditions.
Comorbidities make the management of thoracic
empyema more complicated and difficult. As a result, the
median hospital stay was significantly longer (28 days)
and overall in-hospital mortality was high (30.2%).
The Child-Pugh class is a useful model to predict the
relative risk of mortality in patients with end-stage liver
disease, with or without surgical intervention.9,15,16 In thegery c May 2012
FIGURE 2. Propensity analysis. Distribution of propensity scores in the
nonthoracoscopy and thoracoscopy groups before (A, n ¼ 63) and after
(B, n ¼ 38) matching.
TABLE 6. Propensity analysis baseline characteristics and clinical
outcomes between patients undergoing thoracoscopic and
nonthoracoscopic management
Thoracoscopy
(N ¼ 19)
Nonthoracoscopy
(N ¼ 19)
Variables
No. (%), or
median (range)
No. (%), or
median (range)
P
value
Age, y 57.5 (38–80) 60.5 (38–77) .676
Male 14 (73.7%) 13 (68.4%) 1.000
Ever smoker 12 (63.2%) 11 (57.9%) 1.000
Right sided 12 (63.2%) 12 (63.2%) 1.000
Comorbidity
Malignancy 7 (36.8%) 6 (31.6%) 1.000
Diabetes mellitus 4 (21.1%) 5 (26.3%) 1.000
Hepatic hydrothorax 6 (31.6%) 7 (36.8%) 1.000
Chronic renal
insufficiency
4 (21.1%) 3 (15.8%) 1.000
Congestive heart failure 3 (15.8%) 1 (5.3%) .604
Child-Pugh class
A 9 (47.4%) 8 (42.1%) 1.000
B 4 (21.1%) 5 (26.3%) 1.000
C 6 (31.6%) 6 (31.6%) 1.000
Cause of empyema
Pneumonia 10 (52.6%) 10 (52.6%) 1.000
Hepatic hydrothorax 6 (31.6%) 7 (36.8%) 1.000
Others 3 (15.8%) 2 (10.5%) 1.000
Positive culture
Empyema 12 (63.2%) 10 (52.6%) .743
Blood 3 (15.8%) 4 (21.1%) 1.000
Causing pathogen
Klebsiella pneumoniae 4 (21.1%) 2 (10.5%) .659
MRSA 5 (26.3%) 1 (5.3%) .180
Escherichia coli 1 (5.3%) 1 (5.3%) 1.000
Others 8 (42.1%) 9 (47.4%) 1.000
Total hospital stay, d 30 (13–150) 28 (5–52) .139
ICU stay, d 6 (0–70) 13 (0–89) .044
Mortality 4 (21.1%) 6 (31.6%) .714
MRSA, Methicillin-resistant Staphylococcus aureus; ICU, intensive care unit.
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factor associated with a higher rate of in-hospital mortality
in multivariate analysis. When the mortality rate was strat-
ified by Child-Pugh class, mortality was 14.3%, 5.9%, and
60% in Child-Pugh A, B, and C cases, respectively. In our
patients, sepsis and hepatic failure were common causes of
death. A possible explanation is that the immunity and he-
patic reserve of patients with Child-Pugh class C cirrhosis
were severely compromised, so that retained pus immedi-
ately resulted in sepsis and hepatic failure.1
As for coexisting cancer, 18 of 21 patients (85.7%) had
hepatocellular carcinoma. Although no significance was
found, the cirrhotic patients with malignancy were worth
noticing because their immunity may be weakened by the
cancer.
Multivariate analysis also showed that positive blood cul-
tures were an independent risk factor for a higher rate ofmor-
tality. Bacterial overgrowth, despite antibiotic therapy andThe Journal of Thoracic and Cardrainage, indicates potentially greater bacterial toxicity or
poor host immunity, resulting in poor outcomes. The results
of our study showed that K pneumoniae was the most com-
mon pathogen (26.8%), as in many other patients with non-
cirrhotic empyema in Taiwan.17,18 When taking the cause of
empyema into consideration, K pneumonia was the main
causative pathogen in parapneumonic empyema, whereas E
coli and MRSAwere more common in hepatic hydrothorax.
Our results are comparable to those of a previous report
showing that E coli was the most common pathogen in
cirrhotic patients with spontaneous bacterial empyema.19
One of the most challenging decisions in treating cirrhotic
patients with empyema is to select the optimal intervention
to evacuate the pus and obliterate the pleural space. Open
thoracotomy offers the best efficacy but is considered contra-
indicated in this patient group because of the high risk
of perioperative complications. However, the role ofdiovascular Surgery c Volume 143, Number 5 1149
FIGURE 3. Kaplan–Meier plot of the survival-to-discharge in the non-
thoracoscopy and thoracoscopy groups.
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never been published. We found that thoracoscopic manage-
ment was associated with a better chance of survival. Thor-
acoscopy provides minimal invasive access to the pleural
space and is effective in evacuating viscous pleural fluid, lys-
ing adhesions to promote the drainage of locules, and placing
chest tubes in dependent regions of empyemaunder direct vi-
sualization.20,21 According to our experience, thoracoscopy
drains most of the loculated empyema with minimal
trauma to the pleural cavity, which is especially beneficial
in cirrhotic patients with bleeding tendencies. In addition,
less invasiveness and less surgical trauma of thoracoscopy
also reduce impairment of patient immunity and
inflammatory and cytokine responses.21-24 Although
a repeated operation is sometimes required (12.5%) for
bleeding and inadequate drainage, thoracoscopy is feasible
in selected patients after proper preoperative management.
Limitations
There are limitations to this study because it is retrospec-
tive. Selection bias may exist. It could be argued that the
surgeons tended to choose patients with better general con-
ditions because patients in the thoracoscopic group had
a lower rate of Child-Pugh class C cirrhosis. Although the
multivariate analysis showed that thoracoscopic manage-
ment was an independent factor associated with better sur-
vival, some residual bias could still remain. We then
performed the propensity score-matching method to avoid
the bias. Because of the small case number after meticulous
selection, there was no sufficient power to detect the differ-
ence in mortality rate at discharge (thoracoscopy 21.1% vs
no thoracoscopy 31.5%, P ¼ .714). However, there is still1150 The Journal of Thoracic and Cardiovascular Sura statistically significant reduced hazard favoring thoraco-
scopy (log-rank test P ¼ .035), indicating a prolonged me-
dian survival after the intervention. In addition, treatment
policy was not standardized among physicians and sur-
geons, especially for the timing for thoracoscopic interven-
tion. We believe that a prospective study with precise
definitions of variables and standardized treatment proto-
cols would be helpful in validating our results.CONCLUSIONS
Thoracic empyema in cirrhotic patients represents a clin-
ical challenge, with a high in-hospital mortality rate. Prompt
identification of the causative pathogens and aggressive
evacuation of pus from the pleural space are mandatory to
rescue these vulnerable patients. Our results also showed
that, with proper patient selection, thoracoscopic manage-
ment is feasible andmay provide a better chance of survival.References
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